Codes / ICD10CM / F17.223

F17.223 Nicotine dependence, chewing tobacco, with withdrawal

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Nicotine Dependence, Chewing Tobacco, with Withdrawal
  • ICD-10 Code: F17.223

Summary

Nicotine dependence, chewing tobacco, with withdrawal, is a condition characterized by compulsive use of nicotine-containing chewing tobacco products, leading to physical or psychological reliance, accompanied by withdrawal symptoms when use is reduced or stopped. It involves difficulty controlling use despite awareness of harmful consequences, often resulting in continued consumption to avoid withdrawal effects.

Causes

The primary cause is regular exposure to nicotine, typically through chewing tobacco. Nicotine's addictive properties alter brain chemistry, reinforcing repeated use and creating dependence over time. Withdrawal occurs when nicotine levels drop, triggering physiological and psychological responses as the body adjusts to the absence of the substance.

Risk Factors

  • Regular tobacco product use
  • Younger age of initiation
  • Genetic predisposition to addiction
  • Environmental influences (e.g., peer pressure, parental smoking)
  • Co-occurring mental health conditions

Symptoms

  • Intense cravings for nicotine
  • Inability to quit or reduce use despite attempts
  • Continued use despite health risks
  • Withdrawal symptoms (e.g., irritability, anxiety, difficulty concentrating) when not using
  • Increased appetite or weight gain
  • Restlessness or agitation

Diagnosis

Diagnosis relies on patient history, self-reported use patterns, and clinical evaluation. Healthcare providers may use standardized questionnaires or interviews to assess dependency levels and rule out other conditions. Withdrawal symptoms are confirmed by their onset after reducing or stopping use and their resolution with nicotine replacement or resumption of use.

Treatment Options

  • Nicotine Replacement Therapies (NRT): Patches, gums, or lozenges to reduce withdrawal
  • Behavioral Therapy: Counseling or support groups to address psychological dependence
  • Medications: Prescription drugs (e.g., varenicline, bupropion) to reduce cravings
  • Supportive Care: Monitoring and management of withdrawal symptoms

Prognosis and Follow-Up

Prognosis varies based on individual factors, including motivation to quit and access to treatment. Follow-up care is essential to monitor progress, address relapse risks, and adjust treatment plans. Long-term abstinence is achievable with consistent support and intervention.

Complications

  • Increased risk of oral cancer, gum disease, and tooth loss
  • Cardiovascular issues (e.g., hypertension, heart disease)
  • Respiratory problems
  • Worsening of co-occurring mental health conditions
  • Social or occupational impairment

Lifestyle & Prevention

  • Avoid triggers (e.g., stress, social settings) that prompt use
  • Engage in stress-reduction techniques (e.g., exercise, mindfulness)
  • Seek support from friends, family, or professional resources
  • Consider nicotine-free alternatives for oral stimulation
  • Educate on the risks of chewing tobacco use

When to Seek Professional Help

Seek help if withdrawal symptoms are severe, if attempts to quit have failed, or if use continues despite health concerns. Professional guidance can provide tailored strategies and support for managing dependence and withdrawal.

Tips for Medical Coders

Document the presence of nicotine dependence related to chewing tobacco and confirm withdrawal symptoms (e.g., irritability, cravings) to support the F17.223 code. Ensure clinical notes specify the substance (chewing tobacco) and the withdrawal component to meet coding criteria.

Book a walkthrough

F17.223 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.